Zhejiang Hisoar Pharmaceutical Co Ltd (002099) — Cash Flow Reinvestment Rate
Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a Cash Flow Reinvestment Rate of 1.07x as of September 2025, reinvesting CN¥16.52 Million (capex CN¥16.52 Million ) from operating cash flow of CN¥15.48 Million. Explore Zhejiang Hisoar Pharmaceutical Co Ltd (002099) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Hisoar Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2004–2024)
Historical reinvestment intensity for Zhejiang Hisoar Pharmaceutical Co Ltd across 21 annual periods. Also explore 002099 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Zhejiang Hisoar Pharmaceutical Co Ltd (2004–2024)
Year-by-year capital reinvestment analysis for Zhejiang Hisoar Pharmaceutical Co Ltd. For live market cap and broader valuation context, see market cap of Zhejiang Hisoar Pharmaceutical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.84x | CN¥146.11 Million | CN¥174.83 Million | CN¥122.11 Million | ▲ +10.7% |
| 2023 | 0.76x | CN¥181.63 Million | CN¥240.54 Million | CN¥153.08 Million | ▼ -86.3% |
| 2022 | 5.50x | CN¥638.56 Million | CN¥116.09 Million | CN¥179.42 Million | ▲ +16.4% |
| 2021 | 4.72x | CN¥483.56 Million | CN¥102.36 Million | CN¥229.56 Million | ▲ +3294.3% |
| 2020 | 0.14x | CN¥74.30 Million | CN¥533.87 Million | CN¥74.18 Million | ▼ -91.8% |
| 2019 | 1.70x | CN¥1.04 Billion | CN¥612.40 Million | CN¥160.64 Million | ▲ +21.6% |
| 2018 | 1.40x | CN¥1.11 Billion | CN¥791.45 Million | CN¥255.78 Million | ▼ -38.4% |
| 2017 | 2.27x | CN¥232.73 Million | CN¥102.68 Million | CN¥148.99 Million | ▲ +385.4% |
| 2016 | 0.47x | CN¥293.90 Million | CN¥629.42 Million | CN¥124.31 Million | ▼ -53.7% |
| 2015 | 1.01x | CN¥465.94 Million | CN¥462.16 Million | CN¥296.36 Million | ▲ +14.2% |
| 2014 | 0.88x | CN¥169.06 Million | CN¥191.56 Million | CN¥169.06 Million | ▼ -80.9% |
| 2013 | 4.63x | CN¥281.79 Million | CN¥60.85 Million | CN¥281.79 Million | ▲ +96.1% |
| 2012 | 2.36x | CN¥426.79 Million | CN¥180.73 Million | CN¥426.79 Million | ▲ +0.5% |
| 2011 | 2.35x | CN¥217.52 Million | CN¥92.62 Million | CN¥217.52 Million | ▲ +190.0% |
| 2010 | 0.81x | CN¥146.51 Million | CN¥180.88 Million | CN¥146.51 Million | ▲ +48.7% |
| 2009 | 0.54x | CN¥53.60 Million | CN¥98.38 Million | CN¥53.60 Million | ▼ -81.6% |
| 2008 | 2.95x | CN¥90.40 Million | CN¥30.61 Million | CN¥90.40 Million | ▲ +34.1% |
| 2007 | 2.20x | CN¥112.61 Million | CN¥51.14 Million | CN¥112.61 Million | ▲ +32.8% |
| 2006 | 1.66x | CN¥102.59 Million | CN¥61.88 Million | CN¥102.59 Million | ▼ -18.9% |
| 2005 | 2.04x | CN¥73.74 Million | CN¥36.07 Million | CN¥73.74 Million | ▲ +103.6% |
| 2004 | 1.00x | CN¥42.54 Million | CN¥42.36 Million | CN¥42.54 Million | — |